Sagent Pharmaceuticals Expands into Diagnostic Dye Market with Bludigo® Launch Sagent Pharmaceuticals has partnered with Provepharm to launch Bludigo®, an FDA-approved indigo carmine injection, marking its entry into the diagnostic dye sector.

Sagent Pharmaceuticals Expands into Diagnostic Dye Market with Bludigo® Launch #United_States #Schaumburg #Sagent_Pharmaceuticals #Bludigo #Provepharm